You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Dementias
 •Encephalitis
 •Lewy Body Disease
 •Movement Disorders
 •Alert me on articles by topic

Inflammation in Neurodegenerative Disease

Good, Bad, or Irrelevant?

Arch Neurol. 2000;57:786-788.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INFLAMMATION IS a routine consequence of general body tissue injury in higher organisms. Classic inflammation, with infiltration of lymphocytes and/or macrophages also occurs in the central nervous system, notably following brain injury from stroke or trauma, as well as in various "autoimmune" or infectious cerebral disorders. However, brains of patients with degenerative diseases of the central nervous system, such as Alzheimer, Pick, Parkinson, or Huntington diseases, do not generally show classic signs of inflammation. Nevertheless, a large body of work, notably pioneered by E. G. McGeer, PhD, P. L. McGeer, MD, PhD, J. Rogers, PhD, and colleagues, has shown that despite the absence of notable lympho-infiltrative processes, there is, indeed, neuropathological evidence for immune activation in the most common neurodegenerative disease in aging humans, namely, Alzheimer disease (AD).1-4 Abnormal deposition of complement components, acute-phase reactants, and various cytokines, up-regulation of cyclooxygenase-2, and microgliosis with expression of class II major histocompatibility . . . [Full Text of this Article]


RELATED ARTICLE

Cortical Inflammation in Alzheimer Disease but Not Dementia With Lewy Bodies
Claire E. Shepherd, Emma Thiel, Heather McCann, Antony J. Harding, and Glenda M. Halliday
Arch Neurol. 2000;57(6):817-822.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.